A case report on Rubinsein-Taybi syndrome associated with a de novo CREBBP gene mutation
Article in Asian Journal of Surgery (April 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment
Article in Pharmacology & Therapeutics (March 2024)
Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement
Article in Journal of Medical Genetics (March 2024)